IDEAL International Conference 2017
Research, Regulation, and Reimbursement in Surgery and Technologies
May 4th-5th 2017, New York Academy of Medicine, New York City
Twitter @IDEALCollab #IDEAL2017
- Learn about the latest developments in the scientific methodology for investigating new surgeries and medical devices
- Hear internationally renowned surgical researchers discussing innovation and evaluation in multiple clinical areas
- Present your research on innovations in surgery and therapeutic technology to an international audience of clinicians, scientists, manufacturers and regulators
- Learn about IDEAL pathways for innovation in medicine and perspectives on regulation and reimbursement
- IDEAL as EBM framework in surgery, device innovation and interventional care
Promoting innovation and evaluation in modern surgery and other invasive technologies including implants is one of the main challenges in healthcare. IDEAL is a development of Evidence Based Medicine approach designed to provide practical solutions to the real problems of surgery, devices and other complex therapies where randomised trials are often problematic. The second IDEAL international conference will focus on the hottest topics in surgical/interventional care in various clinical areas and celebrate the continuing work of the IDEAL Collaboration. The conference will provide real-world context and a wide variety of perspectives including surgeons, methodologists, professional societies, industry, regulators, ethicists, and payers. Plenary lectures will be intermixed with parallel educational sessions and opportunities for surgeons and scientists to discuss hot topics in surgery, devices and present their own innovative work.
LATEST PROGRAM (21st March) now available IDEAL Agenda 3.21
REGISTRATION Now open at www.ideal-conference2017.com – early registration discount available until April 1st! Registration fees include breakfast and lunch each day of the conference, and CME credits will be available for physicians.
For further information, contact: email@example.com
ABSTRACT SUBMISSION Now open. CLICK HERE to access the submission system and to view the full list of abstract categories.
The submission deadline is April 1st, 2017. Abstracts will be accepted in a wide variety of clinical areas, including but not limited to urology, orthopaedics, vascular surgery, abdominal surgery, and cardiothoracic surgery.
Official invitations can be provided on request to international attendees who may require documentation to obtain a travel visa.
Please assist the IDEAL community by disseminating the meeting flyer to colleagues! IDEAL Conference flyer_3.21
Abstracts should be prepared with reference to the IDEAL stage which applies to the study, including a short discussion of future study directions within the IDEAL framework (see background readings).
IDEAL Background Readings:
- Evaluation and stages of surgical innovations. Barkun et al, 2009. Lancet.
- No surgical innovation without evaluation: the IDEAL recommendations. MuCulloch et al, 2009. Lancet.
- IDEAL-D: a rational framework for evaluating and regulating the use of medical devices. Sedrakyan et al, 2016. BMJ.
- Challenges in evaluating surgical innovation. Ergina et al, 2009. Lancet.
- IDEAL framework for surgical innovation 1: the idea and development stages. McCulloch et al, 2013. BMJ.
- IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages. Ergina et al, 2013. BMJ.
- IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage. Cook et al, 2013. BMJ.
- Practical guide to the Idea, Development and Exploration stages of the IDEAL Framework and Recommendations. Pennell et al, 2016. Br J Surg.
Confirmed Speakers (January 26, 2017):
- Murray Sheldon, MD, Associate Director for Technology and Innovation, FDA
- Vipul Patel, MD, Medical Director, Global Robotics Institute, Celebration, FL
- Binita Ashar, MD, Director, Division of Surgical Devices, Device Evaluation, FDA
- Joel Horovitz, MD, Vice Chair of Surgery, Maimonides Medical Center
- Andrew Carr, MD, Head of Rheumatology and Musculoskeletal Sciences,Univ Oxford
- Danica Marinac-Dabic, MD, PhD, Director, Division of Epidemiology, FDA
- Jesse Berlin, ScD, Vice President and Global Head, Epidemiology, Johnson & Johnson
- Art Sedrakyan, MD, PhD, Prof of Healthcare Policy and Research, Weill Cornell Med
- Ajit Sachdeva, MD, Director, Division of Education, American College of Surgeons
- Peter McCulloch, MD, Professor of Surgical Science and Practice, Univ Oxford
- Philipp Dahm, MD, Professor of Urology, University of Michigan
- Bruce Campbell, MD, Director Medicines & Healthcare Products Registry Agency, UK
- Tammy Clifford, PhD, Vice-President, Medical Device & Rapid Response, CADTH, CA
- Mitchell Roslin, MD, Professor, Hofstra Northwell School of Medicine
- Jack Cronenwett, MD, Chair of Vascular Surgery, Dartmouth-Hitchcock
- Kazuhiro Sase, MD, PhD, Professor, Juntendo University and PMDA, Japan
- Martin Björck, MD, Professor of Vascular Surgery, Uppsala Univ Hospital, Sweden
- Philip Goodney, MD, Associate Professor of Surgery, The Dartmouth Institute
- Sean Tunis, MD, President & CEO, Center for Medical Technology Policy, Baltimore,
- Jim Hu, MD, Ronald Lynch Professor of Urologic Oncology, Weill Cornell Medicine
- Jeffrey Milsom, MD, Chief of Colon and Rectal Surgery, NewYork-Presbyterian
- Jeffrey Levy, MD, Founder and CEO, Case Network
- Martin Martino, MD, Med Director, Minimally Invasive Robotic Surgery, Lehigh Valley
- William Murray, President and CEO, Medical Device Innovation Consortium
- Dawn Bardot, PhD, Vice President, Technology Innovation, MDIC
- David Beard, MD, Professor of Musculoskeletal Sciences, University of Oxford
- Roberto Bergamaschi, MD, PhD, Professor of Surgery, Stony Brook Medicine
- Theodore Lystig, PhD, Director, Corporate Biostatistics, Medtronic
- Jose Merino, MD, US Clinical Research Editor, BMJ
- Stephen Graves, MD, Director, Australian National Joint Replacement Registry
- Rita Redberg, MD, Editor-in-Chief, JAMA Internal Medicine
Jane Blazeby, MD, Prof of Surgery, University of Bristol, UK